<DOC>
	<DOC>NCT01439217</DOC>
	<brief_summary>Specific Aim: Compare the endothelial function, arterial stiffness and components of metabolic syndrome of childhood Acute Lymphoblastic Leukemia (ALL) survivors to healthy sibling controls. Plan: A cross sectional study comparing ALL survivors to sibling controls including measures of endothelial function and arterial stiffness obtained form a peripheral artery tonometry device, height, weight, waist circumference, fasting lipid, glucose and insulin.</brief_summary>
	<brief_title>Endothelial Function, Arterial Stiffness and Components</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<criteria>Survivor: Inclusion 1. Ages 828 (8 is chosen as lower age limit because developmental understanding will allow survivor to follow instructions for procedures, 28 is chosen as upper limit to include age ranges seen for treatment in the pediatric program) 2. Off therapy for at least 6 months and not more than 10 years (6 months Inclusion 1. Biological sibling 2. Ages 828 (when more than one sibling is available the one closest in age will be chosen.)) 1. Uncontrolled medical conditions that could interfere with participation or interpretation of results 2. History of relapsed ALL or history of bone marrow transplantation</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>28 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Acute lymphoblastic leukemia</keyword>
	<keyword>Survivor</keyword>
	<keyword>Sibling control</keyword>
</DOC>